Literature DB >> 9570373

Phloretin-induced apoptosis in B16 melanoma 4A5 cells by inhibition of glucose transmembrane transport.

M Kobori1, H Shinmoto, T Tsushida, K Shinohara.   

Abstract

Phloretin, a naturally occurring dihydrochalcone, is known to inhibit tumor cell growth in vitro and in vivo. To clarify the anti-tumor effects of phloretin, its apoptosis-inducing effects in B16 melanoma 4A5 cells were examined. Phloretin induced the internucleosomal DNA fragmentation typical of apoptosis in B16 melanoma cells. The addition of extracellular glucose remarkably inhibited the phloretin-induced apoptosis in the cells. When apoptosis was strongly induced in the B16 cells by phloretin, protein kinase C activity was inhibited in the cells. Our results suggest that phloretin induced apoptosis in B16 melanoma 4A5 cells mainly through the inhibition of glucose transmembrane transport. Inhibition of protein kinase C activity by phloretin probably promotes the ratio of apoptotic cells in the cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9570373     DOI: 10.1016/s0304-3835(97)00271-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Anticancer agents interacting with membrane glucose transporters.

Authors:  C Granchi; S Fortunato; F Minutolo
Journal:  Medchemcomm       Date:  2016-07-08       Impact factor: 3.597

Review 2.  Metabolic modulation of cancer: a new frontier with great translational potential.

Authors:  Adam Kinnaird; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2015-01-14       Impact factor: 4.599

3.  A metabolomic evaluation of the phytochemical composition of tomato juices being used in human clinical trials.

Authors:  Morgan J Cichon; Ken M Riedl; Steven J Schwartz
Journal:  Food Chem       Date:  2017-01-26       Impact factor: 7.514

4.  Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species.

Authors:  Yuanyuan Liu; Chenghe Fan; Lv Pu; Cui Wei; Haiqiang Jin; Yuming Teng; Mingming Zhao; Albert Cheung Hoi Yu; Feng Jiang; Junlong Shu; Fan Li; Qing Peng; Jian Kong; Bing Pan; Lemin Zheng; Yining Huang
Journal:  J Neurooncol       Date:  2016-03-16       Impact factor: 4.130

Review 5.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

Review 6.  Targeting metabolic transformation for cancer therapy.

Authors:  Daniel A Tennant; Raúl V Durán; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

7.  Development of high-throughput quantitative assays for glucose uptake in cancer cell lines.

Authors:  Mohamed Hassanein; Brandy Weidow; Elizabeth Koehler; Naimish Bakane; Shawn Garbett; Yu Shyr; Vito Quaranta
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

8.  Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.

Authors:  Paolo E Porporato; Suveera Dhup; Rajesh K Dadhich; Tamara Copetti; Pierre Sonveaux
Journal:  Front Pharmacol       Date:  2011-08-25       Impact factor: 5.810

9.  Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.

Authors:  I-Shan Hsieh; Rong-Sen Yang; Wen-Mei Fu
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

10.  Cancer: fundamentals behind pH targeting and the double-edged approach.

Authors:  Tomas Koltai
Journal:  Onco Targets Ther       Date:  2016-10-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.